What is Scientia Vascular?
Scientia Vascular is a leader in neurovascular innovation, developing advanced treatment systems to improve healthcare outcomes. Their specialized product portfolio includes precision guidewires and catheters engineered for efficient access within the brain's neurovasculature. The company's focus is on providing cutting-edge solutions for healthcare professionals and institutions tackling complex neurovascular conditions. Through patented microfabrication processes, Scientia Vascular is dedicated to redefining access technologies and revolutionizing the neurovascular industry.
How much funding has Scientia Vascular raised?
Scientia Vascular has raised a total of $14.3M across 2 funding rounds:
Debt
$350K
Other Financing Round
$14M
Debt (2020): $350K with participation from PPP
Other Financing Round (2024): $14M led by Piper Sandler
Key Investors in Scientia Vascular
Piper Sandler
Piper Sandler is an investment bank and institutional securities firm that provides investment banking, advisory, and capital raising services to a diverse range of clients, including corporations and institutional investors. Their involvement suggests a strategic financial backing aimed at supporting Scientia Vascular's growth and market strategy.
What's next for Scientia Vascular?
With a recent major strategic investment, Scientia Vascular is poised for accelerated growth and market expansion. The company is likely to focus on enhancing its product development pipeline, potentially exploring new applications for its advanced neurovascular technologies. Further strategic partnerships and broader commercialization efforts are anticipated as the company solidifies its position in the competitive healthcare technology landscape. This infusion of capital will be critical in scaling operations and reinforcing its commitment to advancing neurovascular care.
See full Scientia Vascular company page
